Echinaforce COVID-19 Shedding Study

NCT04999098 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped insufficient recruitment

Conditions

COVID-19 Respiratory Infection
SARS-CoV2 Infection

Interventions

DRUG: Echinaforce Forte tablets
DRUG: Echinaforce Chewable tablets
DRUG: Echinaforce tincture

Sponsor

A. Vogel AG

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]